A critical breakthrough in cancer research is emerging with the use of VHH fragments to re-engage mutated p53. This vital tumor inhibitor protein is frequently inactivated in various types of tumors, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research